trendingVideos2292863https://zeenews.india.com/video/india/covid-19-vaccine-india-s-covaxin-gets-dcgi-approval-for-human-clinical-trials-2292863.html)
Videos
COVID-19 Vaccine: India’s COVAXIN gets DCGI approval for human clinical trials
The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.
The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.
Advertisement
More Videos
